—

Carl Zeiss Meditec AG (AFX.DE) — Technical state

As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 53 out of 100 (momentum 76 · quality 36 · valuation 51), as of 2026-11-17.
  • Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-13)
  • Trend: Carl Zeiss Meditec AG trades 7.5% above its 50-day and 22.7% above its 200-day moving average. (as of 2026-11-13)
  • Index seat: Euro-AI 50

Carl Zeiss Meditec makes diagnostic and surgical devices for eye care and for minimally invasive surgery more broadly. Its ophthalmology line includes imaging and measurement tools for eye exams, surgical microscopes, lens implants for cataract treatment, and lasers used in vision-correction procedures.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the AFX.DE overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Trending

Above its 20-, 50- and 200-day — still in an uptrend.

Ranked #38 on today’s Directional Flow — Rising fastest list (scan of 2026-11-16).

The moving-average stack

FAQ · from the current data · as of 2026-11-13

Quick answers

What is the current Closelooknet signal on AFX.DE?

Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AFX.DE above its 50-day and 200-day moving averages?

As of 2026-11-13, Carl Zeiss Meditec AG trades +7.5% above its 50-day and +22.7% above its 200-day average, with the 20-day +0.8% away.

How far is AFX.DE from its 52-week high?

26% below the 52-week high and 58.2% above the 52-week low, as of 2026-11-13.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.